Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Jack Mardekian

ResearcherPublications, citations & collaboration network

Jack Mardekian is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 360 works, 5,831 citations, an h-index of 42 and an i10-index of 125.

360
Works
5,831
Citations
42
h-index
125
i10-index

How has Jack Mardekian's publication output changed over time?

ScholarIQpublication output · 1998–2021

Output grew0% over the shown period — from 1 works in 1998 to 1 in 2021.

1
1
1
1
2
1
2
1
1
199820072014201520162017201820202021

What are the most-cited papers on Jack Mardekian?

ScholarIQmost cited works
Sertraline in Children and Adolescents With Obsessive-Compulsive Disorder
John S. March, Joseph Biederman, Robert Wolkow, Allan Z. Safferman, Jack Mardekian, Edwin H. Cook, Neal R. Cutler, Roberto Domı́nguez, James M. Ferguson, B. Müller, Robert Riesenberg, Murray Rosenthal, F.R. Sallee, Karen Dineen Wagner
JAMA. 1998467 Citations
Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients
Gregory Y.H. Lip, Allison Keshishian, Xiaoyan Li, Melissa Hamilton, Cristina Masseria, Kiran Gupta, Xuemei Luo, Jack Mardekian, Keith Friend, Anagha Nadkarni, Xianying Pan, Onur Başer, Steven Deitelzweig
S62532593. 2018321 CitationsOPEN ACCESS
Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin
Allison Keshishian, Shital Kamble, Xianying Pan, Jack Mardekian, Ruslan Horblyuk, Melissa Hamilton, Gregory Y.H. Lip
S206235894. 2016261 CitationsOPEN ACCESS
Propensity score matching and inverse probability of treatment weighting to address confounding by indication in comparative effectiveness research of oral anticoagulants
Victoria Allan, Sreeram V Ramagopalan, Jack Mardekian, Aaron Jenkins, Xiaoyan Li, Xianying Pan, Xuemei Luo
Journal of Comparative Effectiveness Research. 2020181 CitationsOPEN ACCESS
Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in “real-world” clinical practice
Xiaoyan Li, Steve Deitelzweig, Allison Keshishian, Melissa Hamilton, Ruslan Horblyuk, Kiran Gupta, Xuemei Luo, Jack Mardekian, Keith Friend, Anagha Nadkarni, Xianying Pan, Gregory Y.H. Lip
S206235894. 2017162 CitationsOPEN ACCESS

Related on ScholarIQ

Pfizer (United States)
Institution
Sertraline in Children and Adolescents With Obsessive-Compulsive Disorder
Paper
Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients
Paper
Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin
Paper
Propensity score matching and inverse probability of treatment weighting to address confounding by indication in comparative effectiveness research of oral anticoagulants
Paper
Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in “real-world” clinical practice
Paper
470M+ articles · free account